The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma

PF-04191834 Single Dose Bronchodilatory Study In Asthma.

NCT00723021 ·Status: COMPLETED ·Phase: PHASE2

Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients

NCT02126865 ·Status: COMPLETED ·Phase: PHASE1

Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity

NCT00217854 ·Status: COMPLETED ·Phase: NA

Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy Alone

NCT01458886 ·Status: WITHDRAWN ·Phase: PHASE2

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

NCT00024544 ·Status: COMPLETED ·Phase: PHASE2

BI 671800 ED in Steroid-naive Asthmatic Patients

NCT01092143 ·Status: COMPLETED ·Phase: PHASE2

Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines

NCT04412044 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powder 100 mcg/25 mcg and BREO ELLIPTA 100 mcg/25 mcg in Participants With Asthma

NCT07223294 ·Status: WITHDRAWN ·Phase: PHASE3

Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma

NCT03971539 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma

NCT02573233 ·Status: COMPLETED ·Phase: PHASE2

Bosentan for Poorly Controlled Asthma

NCT00815347 ·Status: TERMINATED ·Phase: PHASE2

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

NCT02031640 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma

NCT02528214 ·Status: COMPLETED ·Phase: PHASE3

Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis

NCT02280616 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics

NCT02821416 ·Status: COMPLETED ·Phase: PHASE3

BI 671800 in Asthmatic Patients on Inhaled Corticosteroids

NCT01103349 ·Status: COMPLETED ·Phase: PHASE2

Study of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis

NCT02049294 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

NCT01947946 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma

NCT03782532 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma

NCT00781443 ·Status: COMPLETED ·Phase: PHASE2

Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids

NCT01458912 ·Status: WITHDRAWN ·Phase: PHASE2

A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection

NCT02491684 ·Status: COMPLETED ·Phase: PHASE2

A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

NCT02040779 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

NCT02513160 ·Status: COMPLETED ·Phase: PHASE3

Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled

NCT02853578 ·Status: SUSPENDED ·Phase: PHASE3